Photo by Allan Foster via Flickr Creative Commons
Researchers at Children’s Hospital Los Angeles believe they have found a new approach to killing acute lymphoblastic leukemia (ALL) cells.
The discovery of a "fusion toxin that specifically targets cancer cells," could provide a treatment option for patients who become resistant to chemotherapy, according to a hospital news release.
"Although we have made tremendous progress in the treatment of leukemia, Dr. Heisterkamp and her colleagues’ research into drug-resistant disease fills a crucial need," said Brent Polk, MD, director of The Saban Research Institute.
ALL, the most commonly diagnosed cancer in children, also accounts for 30% of adult leukemia.